WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced on Tuesday the appointment of Paul Gama as the new chair of the CHPA board of directors. Gama was elected on April 13, 2020, along with other new board members, at CHPA’s annual membership meeting conducted, for the first time ever, in a virtual forum online.
WASHINGTON — The Consumer Healthcare Products Association (CHPA) announced the appointment of Dr. John Troup as vice president for scientific affairs and dietary supplements, a brand-new position within CHPA. Dr. Troup has wide-ranging experience in the health, nutrition and dietary supplements sectors, including extensive work in clinical and product development, as well as regulatory affairs.
WASHINGTON — The United States Senate voted, 72-18, on Thursday to confirm Dr. Stephen Hahn as Commissioner of Food and Drugs. Health and Human Services Secretary Alex Azar issued the following statement: “I congratulate Dr. Hahn and thank the Senate for prioritizing his nomination. President Trump has chosen a superbly qualified leader for FDA, and
WASHINGTON — The Consumer Healthcare Products Association (CHPA) applauds Tuesday’s passage in the U.S. Senate of S. 2740, the Over-the-Counter Drug Safety, Innovation, and Reform Act by a vote of 91-2. “Thanks to today’s decisive Senate action, our nation is one step closer to having a modern over-the-counter (O-T-C) regulatory framework that will better serve
WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced that Beth Allgaier has been named senior vice president, business development and industry relations. Allgaier will be responsible for the association’s membership, education, and meetings functions, in addition to serving as chief liaison to the retail community. She will be a member of the association’s senior
WASHINGTON — The Consumer Healthcare Products Association (CHPA) submitted on Thursday a citizen petition to the U.S. Food and Drug Administration (FDA) urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol (CBD) in dietary supplements. “Intense consumer demand and commercial interest
WASHINGTON — The Consumer Healthcare Products Association (CHPA) and American Association of Colleges of Pharmacy (AACP) recently conducted a pilot effort to bolster pharmacy students’ training around over-the-counter (O-T-C) products. Through several CHPA member company donations,144 U.S. schools of pharmacy received over 100 different O-T-C medicines, medical devices, and dietary supplements to educate and prepare
WASHINGTON — Due to changes in the American diet and updates in nutrition science, the U.S. Food and Drug Administration (FDA) mandated new label requirements for foods and dietary supplements. The label changes, ranging from measuring folic acid in micrograms of dietary folate equivalents (DFEs) to including added sugar and its percentage of daily value,
WASHINGTON – The Consumer Healthcare Products Association (CHPA) concluded their 2019 Annual Executive Conference, held from March 17-19, at the Boca Raton Resort and Club, in Boca Raton, Fla. More than 300 executives from the over-the-counter (OTC) drug, dietary supplement, and consumer medical device sectors heard from an impressive lineup of speakers, including renowned presidential historian and Pulitzer Prize-winning